Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Buy rating on Hologic (NASDAQ:HOLX) and maintained a price target of $90.
September 17, 2024 | 9:31 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson has reiterated a Buy rating on Hologic, maintaining a price target of $90, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $90 price target by Needham suggests a positive outlook for Hologic. This can boost investor confidence and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100